Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 27, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Halozyme Therapeutics, Inc.
| 17.52K |
$36.10 | -$735,068.20 | +2.66% | 676.74K |
Feb 16
| |||||||
Halozyme Therapeutics, Inc.
| 21.22K |
$35.91 | -$885,361.05 | +3.33% | 659.22K |
Feb 15
| |||||||
Halozyme Therapeutics, Inc.
| 14.34K |
$35.49 | -$601,307.07 | +2.30% | 638K |
Feb 10
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$28.28 | -$864,630.00 |
—
| 623.67K |
Aug 29 - Aug 31
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$28.68 | -$888,720.00 |
—
| 623.67K |
Aug 15 - Aug 17
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$28.48 | -$876,650.00 |
—
| 623.67K |
Jul 25 - Jul 27
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$29.24 | -$874,750.00 |
—
| 623.67K |
Mar 7 - Mar 9
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
| -10.00K |
—
|
—
| -1.58% | 623.67K |
Mar 1
| |||||||
Halozyme Therapeutics, Inc.
| 9.95K |
$49.26 | -$544,864.86 | +1.60% | 633.67K |
Feb 16
| |||||||
Halozyme Therapeutics, Inc.
| 6.2K |
$49.20 | -$339,086.40 | +1.00% | 623.72K |
Feb 15
| |||||||
Halozyme Therapeutics, Inc.
| 30.34K |
$48.92 | -$1,650,316.20 | +5.17% | 617.52K |
Feb 10 - Feb 12
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$32.84 | -$1,090,350.00 |
—
| 587.18K |
Feb 7 - Feb 9
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$32.98 | -$1,099,349.00 |
—
| 587.18K |
Jan 17 - Jan 19
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$36.39 | -$1,303,501.60 |
—
| 587.18K |
Dec 13 - Dec 15
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$34.03 | -$1,161,826.38 |
—
| 587.18K |
Nov 15 - Nov 17
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
| 6.2K |
$34.43 | -$237,291.56 | +1.07% | 587.18K |
Feb 15 - Feb 16
| |||||||
Halozyme Therapeutics, Inc.
| 43.82K |
$34.28 | -$1,679,236.32 | +8.16% | 580.98K |
Feb 10 - Feb 14
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$27.24 | -$1,257,767.77 |
—
| 537.16K |
Nov 8
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$27.38 | -$1,271,389.86 |
—
| 537.16K |
Oct 4
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$28.52 | -$1,385,846.08 |
—
| 537.16K |
Sep 7
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$27.89 | -$1,322,576.04 |
—
| 537.16K |
Aug 10
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$30.32 | -$1,565,650.00 |
—
| 537.16K |
Jul 6
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$27.16 | -$1,249,950.00 |
—
| 537.16K |
Jun 7
|
Scheduled
| ||||||
Quest Diagnostics Inc
| 1.36K |
—
|
—
| +27.83% | 6.26K |
May 25
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$28.84 | -$1,418,098.66 |
—
| 537.16K |
May 11
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$28.60 | -$1,394,250.00 |
—
| 537.16K |
Apr 5
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$30.42 | -$1,576,454.44 |
—
| 537.16K |
Mar 1
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
| 19.84K |
$48.69 | -$949,990.59 | +3.84% | 537.16K |
Feb 22
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Halozyme Therapeutics, Inc.
| 14.49K |
$49.84 | -$709,871.12 | +2.88% | 517.32K |
Feb 14
| |||||||
Halozyme Therapeutics, Inc.
| 32.31K |
$50.21 | -$1,595,103.96 | +6.87% | 502.83K |
Feb 10 - Feb 12
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$31.25 | -$1,658,917.64 |
—
| 470.52K |
Feb 1
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
| -10.00K |
—
|
—
| -2.08% | 470.52K |
Nov 30
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$27.70 | -$1,303,567.72 |
—
| 480.52K |
Nov 25
| |||||||
Halozyme Therapeutics, Inc.
| -10.00K |
—
|
—
| -2.04% | 480.52K |
Aug 14
| |||||||
Quest Diagnostics Inc
| 1.53K |
—
|
—
| +45.48% | 4.9K |
May 19
| |||||||
Halozyme Therapeutics, Inc.
| 19.84K |
$21.83 | -$425,925.13 | +4.22% | 490.52K |
Feb 22
| |||||||
Halozyme Therapeutics, Inc.
| 14.49K |
$21.10 | -$300,548.40 | +3.18% | 470.68K |
Feb 14
| |||||||
Halozyme Therapeutics, Inc.
| 16.54K |
$20.00 | -$325,180.00 | +3.76% | 456.19K |
Feb 12
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.